Sangamo Therapeutics, Inc.
GBY.DE
|
XETRA
|
0 Sledující
Company Quality
Profitability Score
0/100
Solvency Score
29/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
CEO
405
Zaměstnanci
Brisbane California
Centrála
US
Země
Key Metrics TTM
Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.